Intelligent Health.tech Issue 22 | Page 52

ARTIFICIAL INTELLIGENCE

HUMA COMPLETES SERIES D AS IT LAUNCHES HUMA CLOUD PLATFORM WITH GENAI INTEGRATIONS TO BRING DIGITAL- FIRST CARE AND RESEARCH

Building and launching a scalable digital health product that meets regulatory demands typically takes a few years to deliver . Global healthcare AI company Huma Therapeutics Limited has announced the completion of its Series D funding round to help cut that time down to days as it launches the Huma Cloud Platform . The platform offers no code configuration of regulated disease management tools for any therapeutic area , a library of pre-built modules and device connectivity capabilities , a cloud-agnostic framework for flexible hosting , readily available APIs and integration capabilities , the ability to host and deploy diagnostic and predictive AI algorithms , a marketplace , and more to advance digital-first care and research .

Alongside its Series D , Huma is also announcing the launch of its Huma Cloud Platform – a technology ecosystem designed not only to support the company ’ s own digital health initiatives , but also to empower others to launch and scale their projects efficiently . With its Huma Cloud Platform and the regulatory foundation that it is built on , Huma aims to reduce the time it takes to develop and launch digital health projects at scale from years to as little as a few days .
The Huma Cloud Platform is built to serve the company ’ s existing regulated products . In 2023 , Huma achieved the landmark milestone of becoming the first and only configurable , diseaseagnostic FDA Class II , EuMDR Class IIb , and Saudi FDA Class C platform , enabling rapid , code-free configuration with the ability to host AI / ML models . This regulatory status significantly reduces the cost , time , and risks associated with bringing digital health projects to life through the Huma Cloud Platform .
Huma is now making this platform available to customers which comes with a Software Development Kit ( SDK ) to enable the accelerated development of similar applications or to embed functionalities into their existing solutions .
Dr Juergen Eckhardt , EVP , Head of Leaps by Bayer and Pharmaceuticals Business , Development and Licensing , said : “ Pharmaceutical companies need financially and technically efficient digital solutions to minimise spending on efforts that are duplicative or can ’ t scale . The Huma Cloud Platform enables companies to streamline how they bring digital medicine , companion apps , and data collection capabilities to patients from the R & D phase to post-launch .”
WE ARE HERE TO ACCELERATE THE ADOPTION OF DIGITAL AND AI ACROSS CARE AND RESEARCH . . . WE DO THAT BY MAKING THE BUILDING OF DIGITAL HEALTH SOLUTIONS FOR CARE AND RESEARCH EASY .
Huma has partnered with Google and others to develop new AI models that could enable its Cloud Platform users to care for many times more patients with less work ; for example a feature called ‘ 10x Nurse ’ that significantly reduces administrative tasks and brings automation to the patient review process with a human in the loop .
Dan Vahdat , Founder and CEO of Huma , added : “ We are here to accelerate the adoption of digital and AI across care and research , and we do that by making the building of digital health solutions for care and research easy . We like to think of Huma Cloud Platform much like Shopify but for digital health instead of e-commerce . We believe when digital and AI are scaled , they become affordable for both the poor and the rich . They remain consistent and will help us transition medicine from being reactive to proactive .” �
52 www . intelligenthealth . tech